Live feed07:00:00·1122dPRReleasevia QuantisnowGinkgo Bioworks Strengthens End-to-End R&D Capabilities in Gene Therapy through Acquisition of StrideBio's AAV Capsid Discovery and Engineering Platform AssetsByQuantisnow·Wall Street's wire, on your screen.DNA· Ginkgo Bioworks Holdings Inc.Health Care
